 |
Delegates attending this course will benefit from
an introductory overview of the terminology and classification of
cancer and principle issues in its treatment. Commonly available
anti-cancer drugs will be reviewed, particularly in relation to
mode of action, dose intensity and chemotherapy regimes. This will
lead on to a detailed study of the range of side effects commonly
and uncommonly experienced by cancer patients undergoing chemotherapy
treatment. Quality of life issues will also be discussed in terms
of overall assessment and interpretation of results.
Detailed consideration will then be given to the treatment of major
tumour types: breast, lung, upper gastrointestinal (GI), colorectal,
ovarian and prostate cancer. Each session will be presented by clinicians
active in these areas and will focus on overall patient presentation
and management, cancer diagnosis and staging. Following these sessions,
our experts will lead delegates in interactive group discussions
on the key issues relating to effective management of each tumour
type.
The limitations of cytotoxic drugs currently available are well known. With this in mind, the course includes in-depth discussion on new drug development and identification of new pharmacological targets of particular interest and value. Clinical trial design issues will also be included.
CPD accreditation:
Healthcare’s
programmes are approved by the Faculty of Pharmaceutical Medicine
for CPD accreditation. Details can be supplied on request.
Topics to be covered include:
Cancer: Terminology and classification
Introduction to anti-cancer drugs
-
Side-effects of chemotherapy and radiotherapy
New developments in cancer therapy
Introduction to the major tumour types including: Breast, lung,
colorectal, skin, ovarian, GI and prostate cancer
Clinical trial issues in oncology
Chairmen
Professor Jim Cassidy
University of Glasgow, UK
Professor Jaap Verweij
Erasmus Medical Center
Rotterdam, The Netherlands
Top
|
|
|
Why not also buy a copy of our
PharmaEssentials
Guide to oncology
109 pages (PDF)
More information >>
|
|
Who should attend? |
|
Healthcare’s courses are designed
for both medical and non-medical staff within the pharmaceutical
industry. This course is suitable for clinical research, medical
information, regulatory affairs, biometrics and strategic
marketing personnel.
|
| |
|
Fees |
|
The registration fee is £1,725 plus
VAT. This includes lunch and refreshments throughout the day.
Accommodation costs are not included.
Delegates can register on-line or by completing the booking
form and returning it together with the appropriate payment
to Healthcare Education Services Limited.
Please retain a copy of the booking form for your records.
A reduced academic/NHS fee is available—please contact
Healthcare for details. |
| |
|
Venue / Accommodation |
|
Details of the venue will be supplied on
registration.
Accommodation costs are not included in the course fee. However,
Healthcare has organised a special bed and breakfast
rate at the venue for delegates who require overnight accommodation—details
of how to book will be provided with registration documentation. |
| |
|
